Hugel

Hugel Net Debt / EBITDA

The Net Debt to EBITDA of Hugel (145020.KQ) as of Oct 23, 2026 is -2.45. In the previous year, Net Debt to EBITDA was -3.40 — a change of -28.10% (higher).

Net Debt / EBITDA

-2.45

YoY

-28.10%

Last updated:

Net Debt to EBITDA of Hugel is 2024 -2.45 . Net Debt to EBITDA of Hugel was 2023 -3.40 . It decreases by -28.10% higher compared to the previous year.

The Hugel Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2017
-4.93 KRW
Jan 1, 2018
-5.89 KRW
Jan 1, 2019
-6.62 KRW
Jan 1, 2020
-6.12 KRW
Jan 1, 2021
-4.39 KRW
Jan 1, 2022
-4.14 KRW
Jan 1, 2023
-3.40 KRW
Jan 1, 2024
-2.45 KRW
The Hugel Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
-2.45-28.10%
-3.40-17.73%
-4.14-5.79%
-4.39-28.27%
-6.12-7.49%
-6.62+12.30%
-5.89+19.38%
-4.93+208.98%
-1.60+45.25%
-1.10-145.59%
2.41+30.92%
1.84-4,514.90%
-0.04—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hugel Stock analysis

What does Hugel do? Hugel Inc generates revenue by manufacturing and selling biopharmaceuticals based on clostridium botulinum, with products distributed in both domestic and overseas markets. The company’s portfolio includes botulinum toxins available in 50 unit types, 100 unit types, and 200unit types for treating benign essential blepharospasm and improving moderate to severe glabellar lines. Additionally, the firm offers hyaluronic acid fillers designed for the temporary removal of facial wrinkles, specifically the chaeum premium No.1, the chaeum premium No.2, the chaeum premium No.3m, the chaeum premium No.4, the chaeum MID 20A, the chaeum DEEP 20A, the chaeum SUB-Q 20A, and the chaeum VOLUS 20A. Beyond these medical aesthetics, the business also sells wellages, blue roses, and other cosmetics to its customer base. Hugel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hugel stock

Net Debt to EBITDA of Hugel is -2.45 in 2024.

Net Debt to EBITDA of Hugel changed from -3.40 to -2.45, representing a -28.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA Hugel since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Hugel with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Hugel

All Key Metrics — Hugel